Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Otolaryngology (Ear, Nose, Throat) | Pulmonary/Respiratory Diseases | Immunology | Infections and Infectious Diseases
 Disease Category: Allergy
Location: United States, NY

Trial Information

Study for adults with Hereditary Angioedema (HAE)

Winthrop University Hospital Clinical Trials Center is seeking volunteers with inadequately controlled Hereditary Angioedema (HAE) for a clinical research study to test a medication already approved by the Food and Drug Administration (FDA) to investigate the safety and effectiveness of a higher dosage not approved by the FDA.

Patient Inclusion Criteria: Eligible participants will receive study-related medication and medical care at no cost to them. Compensation travel expenses may also be available. Inclusion criteria:

  • diagnosis of HAE with a documented history of swelling
  • have a history of an average of more than one HAE attack each month of any severity
  • must be receiving the recommended CINRYZE™ (c1 Esterase Inhibitor [Human]) dosing of 1000 U every three to four days via intravenous injection

Patient Exclusion Criteria:

  • N/A

Winthrop University Hospital Clinical Trials Center
222 Station Plaza North Suite 300
Mineola, NY 11501
Phone: 516-663-9582
Fax: 516-663-9587
Email: Clinicaltrials@winthrop.org

View Map

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.